Shorena Janelidze
Shorena Janelidze publishes mostly in Physiology, Psychiatry and Mental health and Neurology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Neurological Disease Mechanisms and Treatments.
- World rank
- #43,049 of 7,710,434 ranked researchers
- Rank in Sweden
- #299 of 71,437
- Works
- 211
- Citations
- 18k
- Citations per work
- 86.8
What does Shorena Janelidze research?
Shorena Janelidze's work is mostly in Medicine (52%), Neuroscience (11%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11152.4%
- Medicine11152.4%
- Everything else6229.5%
- Life Sciences3818.1%
- 1Physiology23% of their works
- 2Psychiatry and Mental health21% of their works
- 3Neurology8% of their works
- 4Molecular Biology7% of their works
- 5Neurology7% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Neurological Disease Mechanisms and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Functional Brain Connectivity Studies
- Neuroinflammation and Neurodegeneration Mechanisms
- Tryptophan and brain disorders
- Amyotrophic Lateral Sclerosis Research
Which keywords describe Shorena Janelidze's research?
The keywords of their largest research topics: Oxidative Stress, Neurodegeneration, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Mild Cognitive Impairment and Cytokines.
- FUS/TLS
- Depression
- Astrocytes
- Functional Connectivity
- Parkinson's Disease
- Cerebral Hypoperfusion
- Cytokines
- Alzheimer's Disease
- Amyloid Hypothesis
- Neurodegeneration
- Oxidative Stress
- Neuroinflammation
- Tau Pathology
- Mild Cognitive Impairment
- Microglia
- Vascular Cognitive Impairment
- a-Synuclein
- Resting-State fMRI
- Synaptic Pruning
- Tryptophan Metabolism
- TDP-43
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Oxidative Stress1774 topics
- Neurodegeneration1704 topics
- Neuroinflammation1543 topics
- Amyloid Hypothesis1291 topic
- Tau Pathology1291 topic
- Alzheimer's Disease1151 topic
- Mild Cognitive Impairment1151 topic
- Cytokines252 topics
- Microglia252 topics
- Cerebral Hypoperfusion191 topic
- Vascular Cognitive Impairment191 topic
- Parkinson's Disease171 topic
- a-Synuclein171 topic
- Functional Connectivity151 topic
- Resting-State fMRI151 topic
- Astrocytes131 topic
- Synaptic Pruning131 topic
- Depression121 topic
- Tryptophan Metabolism121 topic
- FUS/TLS111 topic
- TDP-43111 topic
Where does Shorena Janelidze work?
Shorena Janelidze's main affiliation in the publication record is Lund University, Sweden.
How many publications and citations does Shorena Janelidze have?
OpenAlex counts 211 works and 18,321 citations for Shorena Janelidze, an h-index of 58, ranking #43,049 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Shorena Janelidze
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shorena Janelidze. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.